INDEPENDENT MUTATION OF ARGININE(3500)-]GLUTAMINE ASSOCIATED WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100

被引:0
|
作者
RAUH, G
SCHUSTER, H
SCHEWE, CK
STRATMANN, G
KELLER, C
WOLFRAM, G
ZOLLNER, N
机构
关键词
ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; HAPLOTYPES; GENETIC MUTATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial defective apolipoprotein B-100 (FDB) is characterized by a decreased affinity of low density lipoprotein (LDL) to the LDL receptor resulting in a dominantly inherited increase of plasma LDL. It is postulated that FDB is caused by a G to A mutation at nucleotide 10,708 in exon 26 of the apoB gene creating a substitution of glutamine for arginine in amino acid 3500. The arginine(3500)-->glutamine mutation has been identified on the same haplotype of the apoB gene in several populations from North America and Europe, suggesting that it occurred on a single ancestral gene. Independent mutations were not observed. The purpose of this paper is to report on a family where individuals show a dominantly inherited increase of plasma LDL associated with an independent arginine(3500)-->glutamine mutation as determined by haplotype analysis using polymorphic markers of the apoB gene. The identification of these individuals is strong evidence that the arginine(3500)-->glutamine mutation is causative for the defective binding of apoB-100.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 50 条
  • [41] Frequency of Familial Defective Apolipoprotein B-100 (FDB) in Polish group of hypercholesterolemic patients
    Bednarska-Makaruk, M
    Bisko, M
    Pulawska, M
    Rodo, M
    Roszczynko, M
    Broda, G
    Polakowska, M
    Pytlak, A
    Wehr, H
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 65 - 65
  • [42] PHENOTYPIC-EXPRESSION AND FREQUENCY OF FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100 IN BELGIAN HYPERCHOLESTEROLEMICS
    KOTZE, MJ
    PEETERS, AV
    LANGENHOVEN, E
    WAUTERS, JG
    VANGAAL, LF
    ATHEROSCLEROSIS, 1994, 111 (02) : 217 - 225
  • [43] DNA SCREENING OF SOUTH-AFRICAN HYPERLIPIDEMICS FOR FAMILIAL HYPERCHOLESTEROLEMIA AND FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100
    KOTZE, MJ
    LANGENHOVEN, E
    RETIEF, AE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 194 - 194
  • [44] FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 - A MUTATION OF APOLIPOPROTEIN-B THAT CAUSES HYPERCHOLESTEROLEMIA
    INNERARITY, TL
    MAHLEY, RW
    WEISGRABER, KH
    BERSOT, TP
    KRAUSS, RM
    VEGA, GL
    GRUNDY, SM
    FRIEDL, W
    DAVIGNON, J
    MCCARTHY, BJ
    JOURNAL OF LIPID RESEARCH, 1990, 31 (08) : 1337 - 1349
  • [45] Decreased Bone Mineral Density in Subjects Carrying Familial Defective Apolipoprotein B-100
    Yerges-Armstrong, Laura M.
    Shen, Haiqing
    Ryan, Kathleen A.
    Streeten, Elizabeth A.
    Shuldiner, Alan R.
    Mitchell, Braxton D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : E1999 - E2005
  • [46] TIME-RESOLVED FLUOROMETRY IN THE GENETIC DIAGNOSIS OF FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100
    EGGERTSEN, G
    ERIKSSON, M
    WIKLUND, O
    IITIA, A
    OLOFSSON, SO
    ANGELIN, B
    BERGLUND, L
    JOURNAL OF LIPID RESEARCH, 1994, 35 (08) : 1505 - 1508
  • [47] Detecting familial defective apolipoprotein B-100: three molecular scanning methods compared
    Henderson, BG
    Wenham, PR
    Ashby, JP
    Blundell, G
    CLINICAL CHEMISTRY, 1997, 43 (09) : 1630 - 1634
  • [48] CHARACTERIZATION OF 6 PATIENTS WHO ARE DOUBLE HETEROZYGOTES FOR FAMILIAL HYPERCHOLESTEROLEMIA AND FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100
    RUBINSZTEIN, DC
    RAAL, D
    SEFTEL, H
    PILCHER, G
    COETZEE, GA
    VANDERWESTHUYZEN, DR
    JOURNAL OF MEDICAL GENETICS, 1994, 31 (02) : 172 - 172
  • [49] Intima-media thickness and atherosclerotic plaques in familial defective apolipoprotein B-100 and familial hypercholesterolemia
    Kaiser, M
    Temelkova-Kurktschiev, T
    Hanefeld, M
    LIPIDS AND INSULIN RESISTANCE: THE ROLE OF FATTY ACID METABOLISM AND FUEL PARTITIONING, 2002, 967 : 528 - 534
  • [50] A novel LCAT mutation (Phe382→Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100
    Nanjee, MN
    Stocks, J
    Cooke, CJ
    Molhuizen, HOF
    Marcovina, S
    Crook, D
    Kastelein, JP
    Miller, NE
    ATHEROSCLEROSIS, 2003, 170 (01) : 105 - 113